|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
CAM307 NCT00046683
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
CAM314 NCT00086580
|
|
|
|
|
|
|
|
Last Modified: 12/14/2007  First Published: 5/23/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
15 and over
|
|
|
|
NCI
|
|
|
|
CALGB-10102 NCT00061945
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
0 to 70
|
|
|
|
Other
|
|
|
|
H8714 DIMSUM, NCT00048412
|
|
|
|
|
|
|
|
Last Modified: 12/12/2007  First Published: 5/28/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 to 60
|
|
|
|
NCI
|
|
|
|
CALGB-100102 NCT00085449
|
|
|
|
|
|
|
|
Last Modified: 12/10/2008  First Published: 1/20/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 to 65
|
|
|
|
Other, Pharmaceutical / Industry
|
|
|
|
GCLLSG-CLL3X EU-20554, MEDAC-FLUD.10/CLL, NCT00281983
|
|
|
|
|
|
|
|
Last Modified: 5/22/2007  First Published: 12/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
DUMC-1340-99-7 NCI-G99-1617, NCT00004143
|
|
|
|
|
|
|
|
Last Modified: 12/5/2007  First Published: 3/1/2000 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
CLB-19901 NCT00004857, CALGB-19901
|
|
|
|
|
|
|
|
Last Modified: 3/30/2005  First Published: 10/1/2000 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 to 65
|
|
|
|
NCI
|
|
|
|
ECOG-8998 E8998, NCT00006390
|
|
|
|
|
|
|
|
Last Modified: 8/1/2007  First Published: 12/1/2001 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
70 and under
|
|
|
|
NCI
|
|
|
|
MSKCC-01092 NCI-G01-2028, NCT00027560
|
|
|
|